Industry Bulletins | November 16, 2021
Digital Therapeutics Company Click Therapeutics Completes $52 Million Series B Financing
Click Therapeutics, Inc., which provides digital prescription medical treatments, closed a $52 million Series B funding round. Proceeds from the Series B financing will be used to accelerate the development and commercialization of Click’s internal prescription digital therapeutic pipeline and advance Click’s platform capabilities.
The round was led by new investors H.I.G. BioHealth Partners and Accelmed Partners II, with participation from Health Catalyst Capital, Revelation Partners, and a top biotechnology hedge fund, and from existing investors Sanofi Ventures, K2 HealthVentures, Hikma Ventures, and Ridgetop Health. In conjunction with the Series B financing, Click’s Board of . . .